Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Baylor Research Institute patents

Recent patent applications related to Baylor Research Institute. Baylor Research Institute is listed as an Agent/Assignee. Note: Baylor Research Institute may have other listings under different names/spellings. We're not affiliated with Baylor Research Institute, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Baylor Research Institute-related inventors




Date Baylor Research Institute patents (updated weekly) - BOOKMARK this page
04/27/17Anti-cd40 antibodies and uses thereof
04/20/17Methods and compositions for treating autoimmune and inflammatory conditions
04/06/17Methods and compositions for treating allergy and inflammatory diseases
03/09/17Mir-320e and colorectal cancer
12/29/16Triheptanoin for the treatment of glucose transport 1 deficiency
12/29/16Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)
11/17/16Novel vaccines against hpv and hpv-related diseases
10/13/16Fatty acid treatment for cardiac patients
10/13/16Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosis
09/15/16Nuclear localization of glp-1 stimulates myocardial regeneration and reverses heart failure
04/28/16Ulcerative colitis (uc)-associated colorectal neoplasia markers
03/10/16Compositions and methods for the systemic treatment of arthritis
02/04/16Glycogen or polysaccharide storage disease treatment method
02/04/16Multivariable antigens complexed with targeting humanized monoclonal antibody
01/28/16Antigen presenting cell targeted cancer vaccines
12/24/15Methods and compositions for treating breast cancer with dendritic cell vaccines
12/03/15Urinary triaosylceramide (gb3) as a marker of cardiac disease
11/05/15Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis
10/22/15Antigen presenting cell targeted vaccines
06/18/15Anti-interferon alpha monoclonal antibodies and methods of use
05/14/15Early detection of tuberculosis treatment response
04/16/15Fatty acid treatment for cardiac patients
03/12/15Identification of metastasis-specific mirna and hypomethylation signatures in human colorectal cancer
03/05/15Enhancement of pathogen-specific memory th17 cell responses
12/11/14Compositions and methods for the systemic treatment of arthritis
10/30/14Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/14Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo
09/25/14Glycogen or polysaccharide storage disease treatment method
08/21/14Anti-cd40 antibodies and uses thereof
08/14/14Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)
07/17/14Compositions and methods to immunize against hepatitis c virus
06/26/14Module-level analysis of peripheral blood leukocyte transcriptional profiles
05/08/14Antigen presenting cell targeted anti-viral vaccines
11/07/13Fatty acid treatment for cardiac patients
08/01/13Nutrient sensor
08/01/13Agent and stabilizing membrane protein
07/18/13Unique transcriptional signatures in the blood of clinical responders
06/27/13Micro rna-148a as a biomarker for advanced colorectal cancer
05/16/13Dendritic cells loaded with heat shocked melanoma cell bodies
05/16/13Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements
03/14/13Reprogramming immune environment in breast cancer via dendritic cells
02/28/13Controlling allergy and asthma by activating human dcs via dectin-1 or toll-like receptor 2 (tlr2)
02/28/13Self-assembled bead-based multiplexed assay for antigen-specific antibodies
01/31/13Dendritic cell (dc)-vaccine therapy for pancreatic cancer
01/17/13Subsets of antigen-presenting cells (apcs) in the human vagina and their distinct functions
01/10/13Establishment of patient- or person- specific cardiac myocyte cell lines from human induced pluripotent stem cells (ipscs)
01/03/13Glycogen or polysaccharide storage disease treatment method
12/20/12Analysis of total homocysteine and methylmalonic acid in plasma by lc-ms/ms from a plasma separator device (psd)
12/13/12Immunoglobulin-like transcript (ilt) receptors as cd8 antagonists
12/06/12Sle-dc-mediated enhanced igg- and iga-secreting b cell responses
11/29/12Compositions and methods to immunize against hepatitis c virus
11/22/12Detecting dna mismatch repair-deficient colorectal cancers
10/18/12Changes in the expression of mir-200c/141 cluster of micrornas as biomarkers for epithelial-to-mesenchymal transition in human colorectal cancer metastasis
10/11/12Compositions and methods for the systemic treatment of arthritis
09/20/12Vaccines based on targeting antigen to dcir expressed on antigen-presenting cells
09/20/12Long interspersed nuclear elements (line-1) and alu hypomethylation as biomarkers for colorectal cancer metastasis
09/20/12Line-1 hypomethylation as a biomarker for early-onset colorectal cancer
09/20/12Biomarkers for predicting the recurrence of colorectal cancer metastasis
09/13/12Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
09/13/12Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions
08/23/12Diagnostic and therapeutic uses for b cell maturation antigen
08/16/12Msh3 expression status determines the responsiveness of cancer cells to the chemotherapeutic treatment with parp inhibitors and platinum drugs
07/12/12Compositions and methods of alteration of autoimmune diseases
06/14/12Compositions and methods for the systemic treatment of arthritis
05/31/12Induction of pancreatic stem cells by transient overexpression of reprogramming factors and pdx1 selection
Patent Packs
05/24/12Enhancement of pathogen-specific memory th17 cell responses
05/17/12Targeting antigens to human dendritic cells via dc-asialoglycoprotein receptor to produce il-10 regulatory t-cells
02/16/12Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
02/02/12Il-18 receptor as a novel target of regulatory t cells in cancer
01/26/12Thymic stromal lymphopoietin (tslp) and ox40 ligand in cancer
01/26/12Anti-inteferon alpha monoclonal antibodies and methods for use
01/12/12Neurod1 gene expression in non-endocrine pancreatic epithelial cells (nepecs)
01/05/12Vaccines based on targeting antigen to dcir expressed on antigen-presenting cells
12/22/11Genomic transcriptional analysis as a tool for identification of pathogenic diseases
12/15/11Inhibition of pro-inflammatory cytokine induced response
12/15/11Triheptanoin diet for adult polyglucosan body disease (apbd) treatment
11/10/11Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/03/11Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses
09/08/11Involvement of androgen/androgen receptor pathway in fabry disease
08/18/11Anaplerotic therapy for alzheimer's disease and the aging brain
Patent Packs
07/28/11In-vivo non-viral gene delivery of human vascular endothelial growth factor following islet transplantation
07/14/11Urinary triaosylceramide (gb3) as a marker of cardiac disease
05/26/11Method of treating atrial fibrillation through epicardial lesion
05/12/11Treatment of male-pattern baldness by local induction of the metabolic defect of fabry disease
04/28/11Functionalization of micro- and nano-particles for selective attachment to calcium biomineral surfaces
04/14/11Identification of micrornas (mirnas) in fecal samples as biomarkers for gastroenterological cancers
04/07/11Vaccines directed to langerhans cells
12/30/10Multivariable antigens complexed with targeting humanized monoclonal antibody
12/23/10Antigen presenting cell targeted cancer vaccines
11/25/10Antigen presenting cell targeted vaccines
11/18/10Antigen presenting cell targeted anti-viral vaccines
10/14/10Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease
09/23/10Anti-cd40 antibodies and uses thereof
09/02/10Fatty acid nutritional supplement
07/01/10Large scale pancreatic islet purification
07/01/10Apparatus and the preservation of pancreatic tissue and islet cells for transplantation
06/03/10Hiv vaccine based on targeting maximized gag and nef to dendritic cells
05/06/10Systemic lupus erythematosus diagnostic assay
03/25/10Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
03/18/10Compositions and methods for the systemic treatment of arthritis
03/18/10Compositions and methods for the systemic treatment of arthritis
03/11/10Respiratory syncytial virus renders dendritic cells tolerogenic
03/04/10System and pre-planning a radiation treatment
02/18/10Fatty acid treatment for cardiac patients
12/10/09Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+ t cells
07/30/09Pancreatic islet cell preparation and transplantation
03/19/09Anti-cancer and anti-inflammatory effects of annurca apple extracts and compositions purified therefrom







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Baylor Research Institute in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Baylor Research Institute with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';